Vitamin D: Evidence for its role as a prognostic factor in multiple sclerosis

Journal of the Neurological Sciences

Volumn 311, Issue 1-2, 2011, Pages 19-22

  Mowry, Ellen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Disability; Multiple sclerosis; Randomized controlled trial; Relapse; Vitamin D

Indexed keywords

CALCIFEDIOL; VITAMIN D;

ARTICLE; CROSS-SECTIONAL STUDY; HUMAN; MULTIPLE SCLEROSIS; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RETROSPECTIVE STUDY; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ANIMALS; COMORBIDITY; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; EVIDENCE-BASED MEDICINE; HUMANS; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 81255161781     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.06.035     Document Type: Article

References (46)

1. J.F. Kurtzke Epidemiologic contributions to multiple sclerosis: an overview Neurology 30 1980 61 79 (Pubitemid 10033848)
2. J.E. Norman, J.F. Kurtzke, and G.W. Beebe Epidemiology of multiple sclerosis in US veterans: 2. Latitude, climate, and the risk of multiple sclerosis J Chronic Dis 3 1983 551 559 (Pubitemid 13026050)
3. S.R. Hammond, D.R. English, and J.G. McLeod The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia Brain 123 2000 968 974 (Pubitemid 30224192)
4. M. Alter, E. Kahana, N. Zilber, and A. Miller Multiple sclerosis frequency in Israel's diverse populations Neurology 66 2006 1061 1066 (Pubitemid 44044792)
5. P. Cabre Migration and multiple sclerosis: the French West Indies experience J Neurol Sci 262 2007 117 121 (Pubitemid 47398896)
6. I.A. van der Mei, A.L. Ponsonby, L. Blizzard, and T. Dwyer Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation Neuroepidemiology 20 2001 168 174 (Pubitemid 32718873)
7. I.A. van der Mei, A.L. Ponsonby, T. Dwyer, L. Blizzard, R. Simmons, and B.V. Taylor Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study BMJ 327 2003 316 321
8. J.M. Sutherland, J.H. Tyrer, and M.J. Eadie The prevalence of multiple sclerosis in Australia Brain 85 1962 146 164
9. E.D. Acheson, C.A. Bachrach, and F.M. Wright Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables Acta Psychiatr Scand 147 1960 132 147
10. U. Leibowitz, D. Sharon, and M. Alter Geographical considerations in multiple sclerosis Brain 90 1967 871 886
11. M.J. Goldacre, V. Seagroatt, D. Yeates, and E.D. Acheson Skin cancer in people with multiple sclerosis: a record linkage study J Epidemiol Community Health 58 2004 142 144 (Pubitemid 38130483)
12. K.L. Munger, L.I. Levin, B.W. Hollis, N.S. Howard, and A. Ascherio Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis JAMA 296 2006 2832 2838 (Pubitemid 44969183)
13. 3 Eur J Immunol 30 2000 498 508 (Pubitemid 30098842)
14. K.M. Spach, and C.E. Hayes Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice J Immunol 175 2005 4119 4126 (Pubitemid 41292076)
15. S.L. Hauser, H.L. Weiner, M. Che, M.E. Shapiro, F. Gilles, and N.L. Letvin Prevention of experimental allergic encephalomyelitis (EAE) in the SJL/J mouse by whole body ultraviolet irradiation J Immunol 132 1984 1276 1281 (Pubitemid 14154550)
16. 3-1α- hydroxylase J Clin Endocrinol Metab 86 2001 888 894
17. D.W. Eyles, S. Smith, R. Kinobe, M. Hewison, and J.J. McGrath Distribution of the vitamin D receptor and 1α-hydroxylase in human brain J Chem Neuroanat 29 2005 21 30 (Pubitemid 39602785)
18. S. Riaz, M. Malcangio, M. Miller, and D.R. Tomlinson A vitamin D(3) derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats Diabetologica 42 1999 1308 1313 (Pubitemid 29500967)
19. 3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis J Immunol 174 2005 270 276 (Pubitemid 40007413)
20. P.T. Liu, S. Stenger, H. Li, L. Wenzel, B.H. Tan, and S.R. Krutzik Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response Science 311 2006 1770 1773
21. J. Cadranel, M. Garabedian, B. Milleron, H. Guillozo, G. Akoun, and A.J. Hance 1,25(OH)2D2 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis J Clin Invest 85 1990 1588 1593 (Pubitemid 20176456)
22. S. Chen, G.P. Sims, X.X. Chen, Y.Y. Gu, S. Chen, and P.E. Lipsky Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation J Immunol 179 2007 1634 1647
23. 3 utilize distinct pathways to suppress IL-12 production and modulate rapid differentiation of human monocytes into CD83+ dendritic cells J Immunol 174 2005 2061 2070 (Pubitemid 40223949)
24. M. Ibi, H. Sawada, M. Nakanishi, T. Kume, H. Katsuki, and S. Kaneko Protective effects of 1α,25-(OH)2D3 against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture Neuropharmacology 40 2001 761 771 (Pubitemid 32436453)
25. G. Penna, S. Amuchastequi, C. Cossetti, F. Aquilano, R. Mariani, and F. Sanvito Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol J Immunol 177 2006 8504 8511 (Pubitemid 44895295)
26. I.M. Stromnes, L.M. Cerretti, D. Liggitt, R.A. Harris, and J.M. Governman Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells Nat Med 14 2008 337 342 (Pubitemid 351347910)
27. 3 analog enhances regulatory T cells and arrests autoimmune diabetes in NOD mice Diabetes 51 2002 1367 1374 (Pubitemid 34826601)
28. 3 and mycophenolate mofetil treatment mediate transplant tolerance J Immunol 167 2001 1945 1953 (Pubitemid 32747499)
29. A. Adorini, and G. Penna Control of autoimmune diseases by the vitamin D endocrine system Nat Clin Pract Rheumatol 4 2008 404 412
30. 3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis J Neuroimmunol 103 2000 171 179 (Pubitemid 30079729)
31. 3 leads to early effects within the central nervous system Acta Neuropathol 105 2003 438 448 (Pubitemid 36798839)
32. 3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis Proc Natl Acad Sci USA 93 1996 7861 7864 (Pubitemid 26277129)
33. 3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking J Neurosci Res 85 2007 2480 2490 (Pubitemid 47204762)
34. I.A. van der Mei, A.L. Ponsonby, T. Dwyer, L. Blizzard, B.V. Taylor, and T. Kilpatrick Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia J Neurol 254 2007 581 590 (Pubitemid 46781963)
35. J. Smolders, P. Menheere, A. Kessels, J. Damoiseaux, and R. Hupperts Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis Mult Scler 14 2008 1220 1224
36. E.M. Mowry, L.B. Krupp, M. Milazzo, D. Chabas, J.B. Strober, and A.L. Belman Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis Ann Neurol 67 2010 618 624
37. S.V. Ramagopalan, N.J. Maugeri, L. Handunnetthi, M.R. Lincoln, S.M. Orton, and D.A. Dyment Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D PLoS Genet 5 2009 e1000369
38. D.T. Okuda, R. Srinivasan, J.R. Oksenberg, D.S. Goodin, S.E. Baranzini, and A. Beheshtian Genotype-phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures Brain 132 2009 250 259
39. L.F. Barcellos, J.R. Oksenberg, A.B. Begovich, E.R. Martin, S. Schmidt, and E. Vittinghoff HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course Am J Hum Genet 72 2003 710 716 (Pubitemid 36255969)
40. J. Dausset, L. Degos, and J. Hors The association of the HL-A antigens with diseases Clin Immunol Immunopathol 3 1974 127 149
41. J.L. Haines, M. Ter-Minassian, A. Bazyk, J.F. Gusella, D.J. Kim, and H. Terwedow A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group Nat Genet 13 1996 469 471 (Pubitemid 26256623)
42. S.L. Hauser, and J.R. Oksenberg The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration Neuron 52 2006 61 76 (Pubitemid 44466355)
43. S. Simpson, B. Taylor, L. Blizzard, A.L. Ponsonby, and F. Pittas Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis Ann Neurol 68 2010 193 203
44. W. Mei, Y. Rong, L. Jinming, L. Yongjun, and Z. Hui Effect of homocysteine interventions on the risk of cardiocerebrovascular events: a meta-analysis of randomised controlled trials Int J Clin Pract 64 2010 208 215
45. Y. Song, N.R. Cook, C.M. Albert, M. Van Denburgh, and J.E. Manson Effects of vitamins C and E and beta-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a randomized controlled trial Am J Clin Nutr 90 2009 429 437
46. J.H. Kang, N.R. Cook, J.E. Manson, J.E. Buring, C.M. Albert, and F. Grodstein Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: the women's antioxidant and cardiovascular study Circulation 119 2009 2772 2780